Juan R. Cubillos-Ruiz, Ph.D. is a postdoctoral associate in the Department of Medicine at Weill Cornell Medical College in New York City. Juan obtained his Bachelor of Science degree in Microbiology at Universidad de los Andes (Bogota, Colombia) and completed his Ph.D. in Immunology at Dartmouth Medical School (Hanover, NH, USA) under the mentorship of tumor immunologist Dr. Jose Conejo-Garcia. His Ph.D. research focused on understanding and targeting the immune microenvironment of ovarian cancer. He pioneered the use of RNAi-loaded nanoparticles to re-program dendritic cell function in the tumor microenvironment and received the “John H. Copenhaver, Jr. and William H. Thomas, MD 1952” Predoctoral Fellowship Award for his basic and translational discoveries. Juan’s current research in the laboratory of world-renowned immunologist Dr. Laurie H. Glimcher focuses on understanding how the Endoplasmic Reticulum Stress Response regulates anti-tumor immune responses. Juan has been recipient of research awards from the Bill and Melinda Gates Foundation, the Cancer Research Institute and the Ragon Institute of MGH, MIT and Harvard. His overarching goal is to devise the next generation of targeted immunotherapies and make a decisive difference in the dismal prognosis of the more than 22,000 American women diagnosed every year with ovarian cancer.